Veracyte reported $-36042000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Agilent A:US $ 493M 50M
Anika Therapeutics ANIK:US $ 6.33M 8.56M
Arrowhead Research ARWR:US $ -62379000 32.51M
Biocept BIOC:US $ 0.87M 2.28M
Bruker BRKR:US $ 137.2M 25.2M
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Exact Sciences EXAS:US $ -95.57M 30.77M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Illumina ILMN:US $ -414M 650M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Laboratory Of America LH:US $ 964.7M 51.9M
Ligand Pharmaceuticals LGND:US $ 28.43M 29.92M
Luminex LMNX:US $ 21.3M 3.09M
Myriad Genetics MYGN:US $ -65.7M 63.6M
Rigel Pharmaceuticals RIGL:US $ -19.52M 6.73M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Siemens SIE:GR € 2519M 58M
Sonic Healthcare SHL:AU $ 1.26B 49.1M
Thermo Fisher Scientific TMO:US $ 2924M 24M
Veracyte VCYT:US $ -36.04M 41.77M
Waters WAT:US $ 223.62M 6.35M